Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
---|
01/04/2007 | US20070004669 Mono-, di- or trifluoromethyl derivatives, e.g., 6-amino-9-(2-C-fluoromethyl- beta -D-ribofuranosyl)purine, 2'-C-(fluoromethyl)-5-methylcytidine and 2-amino-9-(2-C-fluoromethyl- beta -D-ribofuranosyl)-3,9-dihydropurin-6-thione; used to treat a hepatitis C virus infection |
01/04/2007 | US20070003957 Real-time linear detection probes: sensitive 5'-minor groove binder-containing probes for PCR analysis |
01/03/2007 | EP1737876A1 Avermectin and avermectin monosaccharide substituted in the 4"-and 4'-position respectively |
01/03/2007 | EP1737472A2 Effective treatment of tumors and cancer with triciribine and related compounds |
01/03/2007 | EP0771213B1 Haemophilus influenzae adherence and penetration proteins |
01/03/2007 | CN1887828A Synthesis process of 18F lebeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst |
01/02/2007 | US7157572 UV excitable energy transfer reagents |
01/02/2007 | US7157486 For therapy and prophylaxis of hepatitis C virus (HCV) infection |
01/02/2007 | US7157448 Acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same |
01/02/2007 | US7157442 Antibacterial compound |
01/02/2007 | US7157441 Administering an anti-virally effective amount of 1', 2' or 3'-modified nucleoside for therapy of hepatitis C virus infection |
01/02/2007 | US7157440 Partial and full agonists of A1 adenosine receptors |
01/02/2007 | US7157434 Nucleoside compounds for treating viral infections |
12/28/2006 | WO2006138396A2 Methods for selective n-9 glycosylation of purines |
12/28/2006 | WO2006137953A1 Phosphono-pent-2-en-1-yl nucleosides and analogs |
12/28/2006 | WO2005086637A3 Anthrax antigens and methods of use |
12/28/2006 | WO2004003138A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
12/28/2006 | US20060293514 Nucleotide lipid ester derivatives |
12/28/2006 | US20060293511 Phosphinoamidite carboxylates and analogs thereof in the synthesis of oligonucleotides having reduced internucleotide charge |
12/28/2006 | US20060293510 Metal complex type nucleic acid |
12/28/2006 | US20060293306 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
12/28/2006 | US20060293284 Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same |
12/27/2006 | EP1736478A1 Methods and compositions for treating flaviviruses and pestiviruses |
12/27/2006 | EP1735338A2 Anthrax antigens and methods of use |
12/27/2006 | EP0638123B1 Bacterial nitroreductase for the reduction of cb 1954 and analogues thereof to a cytotoxic form |
12/27/2006 | CN1886416A Comt抑制剂 Comt inhibitors |
12/27/2006 | CN1886415A Improved synthesis of 2-substituted adenosines |
12/27/2006 | CN1886414A Improved synthesis of 2-substituted adenosines |
12/27/2006 | CN1884294A A kind of compound, its pharmaceutical composition and its medicinal and health uses |
12/27/2006 | CN1292254C Kit for inspecting infection of swine pleuropneumonia actinomyces |
12/27/2006 | CN1292073C Natural antitumor or antiviral substances and use of the same |
12/27/2006 | CN1291994C Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
12/26/2006 | US7153955 Apparatus for use as diagnostic and therapeutic tool in gene therapy |
12/26/2006 | US7153954 Biosynthesis of preferential nucleotide sequences; obtain nucleic acid, incubate with cyanoethyl-N,N,N',N'-tetra-substituted phosphoramidite in the presence of a nucleophilic activator, recover adjusted |
12/26/2006 | US7153948 High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF) |
12/26/2006 | US7153433 Membrane's binding properties with respect to nucleic acids being adjustable by controlling the conditions in an ambient medium, characterized in that membrane is functionalized with deportonable groups |
12/21/2006 | WO2006133611A1 N2-quinolyl or isoquinolyl substituted purine derivatives, the preparation and uses thereof |
12/21/2006 | WO2004092191A3 Polymeric oligonucleotide prodrugs |
12/21/2006 | US20060287320 Preparation of thioarabinofuranosyl compounds and use thereof |
12/21/2006 | US20060287281 Phosphohalohydrins, process for the production thereof and use thereof |
12/21/2006 | US20060287275 Using 5'-sulfoxyoxy adenosine in therapy for tachycardia, cardiovascular disorders, angina, myocardial infraction , antilipemic agents |
12/21/2006 | US20060287274 Phosphoepoxides, method for making same and uses |
12/21/2006 | US20060287271 Prevention or treatment of disorders modulated by P2Y receptors such as type 2 diabetes, cystic fibrosis and cancer |
12/21/2006 | US20060287260 Oligonucleotides comprising a non-phosphate backbone linkage |
12/21/2006 | US20060287223 Remodeling and glycoconjugation of peptides |
12/21/2006 | US20060286561 Propargylethoxyamino nucleotides |
12/21/2006 | CA2611865A1 N2-quinolyl or isoquinolyl substituted purine derivatives, the preparation and uses thereof |
12/20/2006 | CN1882605A Improved expression systems using Sec-system secretion |
12/20/2006 | CN1882593A Fused pentacyclic polyethers |
12/20/2006 | CN1882333A Indole antiviral compositions and methods |
12/20/2006 | CN1880315A N2-quinoline or isoquinoline substituted purine derivative and its preparation method and uses |
12/20/2006 | CN1291034C Method for identifying polynucleotide |
12/20/2006 | CN1290856C Method for producing mixed crystal of disodium 5'-guanylate and disodium 5'-inosinate |
12/20/2006 | CN1290855C Nucleotide analogs with six-membered rings |
12/20/2006 | CN1290845C Process for synthesis of nucleoside analogue |
12/20/2006 | CN1290841C Process for the non-enantiomorph selective synthesis of nucleoside analogues |
12/19/2006 | US7151108 Anticarcinogenic, antiproliferative, and antitumor agents |
12/19/2006 | US7151092 Cytarabine monophosphate prodrugs |
12/19/2006 | US7151089 7-(2'-C-methyl- beta -D-ribofuranosyl)-4-amino-5-(diisopropoxymethyl)-pyrrolo[2,3-d]pyrimidine; treating hepatitis C |
12/19/2006 | US7150966 Determining whether fluorescently labeled compound is phosphorylated via monitoring/measuring shift in polarized fluorescence |
12/19/2006 | CA2259538C Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
12/14/2006 | WO2006133092A1 Methods of treating cancer and other conditions or disease states using lfmau and ldt |
12/14/2006 | WO2006132808A1 Process of making an alpha-anomer enriched 2-deoxy-2,2-diflouro-d-ribofuranosyl sulfonate and use thereof for making a beta nucleoside |
12/14/2006 | WO2005063786A3 Process for fluorocytidine derivatives |
12/14/2006 | US20060281911 Thermolabile hydroxyl protecting groups and methods of use |
12/14/2006 | US20060281907 Halogenated aminoquinolines and methods for forming DNA triplexes |
12/14/2006 | US20060281706 New phosphonate ester derivatives of drugs such as antivirals cidofovir, adefovir, tenofovir, azidothymidine (AZT), or bisphosphonates such as alendronate, or anticancers such as cytosine arabinoside; side effect reduction, less toxic; antiviral |
12/14/2006 | US20060281705 A1 adenosine receptor agonists |
12/14/2006 | CA2689979A1 Process of making an alpha-anomer enriched 2 -deoxy- 2, 2 -difluoro-d-ribofuranosyl sulfonate and use thereof for making a beta nucleoside |
12/14/2006 | CA2609343A1 Methods of treating cancer and other conditions or disease states using lfmau and ldt |
12/13/2006 | EP1731525A1 Nucleotide derivatives and dna microarray |
12/13/2006 | EP1730307A2 Photocleavable fluorescent nucleotides for dna sequencing on chip constructed by site-specific coupling chemistry |
12/13/2006 | CN1878875A Methods and device for DNA sequencing using surface enhanced raman scattering (SERS) |
12/13/2006 | CN1878783A Process for preparing antiviral nucleoside derivatives |
12/13/2006 | CN1289690C Methods and compositions for amplification of RNA sequences |
12/12/2006 | US7148349 Cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs |
12/12/2006 | US7148223 4′-thio-L-xylo furanosyl nucleosides, precursors thereof, preparation and use thereof |
12/12/2006 | US7148207 For therapy of cancer; quick release tablet of fludarabine phosphate in a defined composition of residual contaminants |
12/12/2006 | US7148206 Methods and compositions for treating flaviviruses and pestiviruses |
12/12/2006 | US7148191 Antigenic composition |
12/12/2006 | US7148042 Method of preparing a guanosine-group compound and an intermediate thereof |
12/12/2006 | CA2278056C Gemcitabine derivatives |
12/12/2006 | CA2269943C Method for the production of ivermectin |
12/07/2006 | WO2006128328A1 A process for preparing didanosine |
12/07/2006 | US20060276638 Process of making an alpha-anomer enriched 2-deoxy-2,2-diflouro-d-ribofuranosyl sulfonate and use thereof for making a beta nucleoside |
12/07/2006 | US20060276492 Treating human immunodeficiency and hepatitis B infections; high activity, low toxicity |
12/07/2006 | US20060276428 A1 adenosine receptor agonists |
12/07/2006 | US20060275843 Methods for diagnosing the presence or stage of cancer |
12/07/2006 | US20060275750 Bioreactive agents |
12/06/2006 | EP1727825A1 Labelling reagents, methods for the synthesis of such reagents and methods for the detection of biological molecules |
12/06/2006 | CN1872869A Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase |
12/06/2006 | CN1872868A Method for synthesizing didanosine |
12/06/2006 | CN1872867A Method for separating 5' nucleoside triphosphate continuously |
12/05/2006 | US7145000 Markable compounds for easy synthesis of 3'-[18F] fluoro-3'-deoxynucleotides, and method for their production |
12/05/2006 | US7144995 Fluorescent nitrogenous base and nucleosides incorporating same |
12/05/2006 | US7144872 1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-carboxamides; adenosine receptors (A2A); for stimulating mammalian coronary vasodilatation for therapy and imaging the heart |
12/05/2006 | US7144871 Partial and full agonists of A1 adenosine receptors |
12/05/2006 | US7144868 7-(2'-C-methyl- beta -D-ribofuranosyl)-4-amino-5-(2'-trimethylsilylethyn-1-yl)-pyrrolo[2,3-d]pyrimidine; treating hepatitis C |
12/05/2006 | US7144866 Parasiticides |
12/05/2006 | US7144579 for producing the vectors and suppressing replication/reducing cytotoxicity of vector genome |